BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

27 related articles for article (PubMed ID: 7260004)

  • 1. Obesity is associated with heavy menstruation that may be due to delayed endometrial repair.
    Reavey JJ; Walker C; Murray AA; Brito-Mutunayagam S; Sweeney S; Nicol M; Cambursano A; Critchley HOD; Maybin JA
    J Endocrinol; 2021 May; 249(2):71-82. PubMed ID: 33836495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrauterine hemostatic device: Uterine contraction to expel a device a fundamental mechanism?
    Matsubara S
    J Obstet Gynaecol Res; 2024 Jan; 50(1):141-142. PubMed ID: 37985227
    [No Abstract]   [Full Text] [Related]  

  • 3. Menorrhagia. Current drug treatment concepts.
    van Eijkeren MA; Christiaens GC; Scholten PC; Sixma JJ
    Drugs; 1992 Feb; 43(2):201-9. PubMed ID: 1372218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The response of endometrial blood vessels to intrauterine contraceptive devices: an electron microscopic study.
    Sheppard BL; Bonnar J
    Br J Obstet Gynaecol; 1980 Feb; 87(2):143-54. PubMed ID: 7362802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of intrauterine contraceptive devices on the ultrastructure of the endometrium in relation to bleeding complications.
    Sheppard BL; Bonnar J
    Am J Obstet Gynecol; 1983 Aug; 146(7):829-39. PubMed ID: 6869454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes of plasminogen activator in human uterine tissue induced by intrauterine contraceptive devices.
    Shaw ST; Macaulay LK; Sun NC; Tanaka MS; Roche PC
    Contraception; 1983 Feb; 27(2):131-40. PubMed ID: 6682747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of intrauterine contraceptive device on uterine haemostasis: a morphological study.
    Aparicio SR; Bradbury K; Bird CC; Foley ME; Jenkins DM; Clayton JK; Scott JS; Rajah SM; McNicol GP
    Br J Obstet Gynaecol; 1979 Apr; 86(4):314-24. PubMed ID: 435419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of a progesterone-releasing intrauterine contraceptive device on endometrial blood vessels: a morphometric study.
    Shaw ST; Macaulay LK; Aznar R; González-Angulo A; Roy S
    Am J Obstet Gynecol; 1981 Dec; 141(7):821-7. PubMed ID: 7315908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haemostasis in menstrual endometrium in the presence of an intrauterine device.
    Christiaens GC; Sixma JJ; Haspels AA
    Br J Obstet Gynaecol; 1981 Aug; 88(8):825-37. PubMed ID: 7260004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of prostaglandins and allied substances in uterine haemostasis.
    Hagenfeldt K
    Contraception; 1987 Jul; 36(1):23-35. PubMed ID: 3311624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A risk-benefit assessment of the levonorgestrel-releasing intrauterine system.
    Sturridge F; Guillebaud J
    Drug Saf; 1996 Dec; 15(6):430-40. PubMed ID: 8968696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endometrial haemostasis and menstruation.
    Davies J; Kadir RA
    Rev Endocr Metab Disord; 2012 Dec; 13(4):289-99. PubMed ID: 23180227
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.